Screening for Type 2 diabetes--should it be now? (Q30911757)

27 June 2017

1 reference

title

Screening for Type 2 diabetes--should it be now? (English)

1 reference

27 June 2017

1 reference

Borch-Johnsen K

1

1 reference

27 June 2017

Lauritzen T

series ordinal

2

1 reference

27 June 2017

Glümer C

series ordinal

3

1 reference

27 June 2017

Sandbaek A

series ordinal

4

1 reference

27 June 2017

1 March 2003

1 reference

27 June 2017

1 reference

27 June 2017

20

1 reference

27 June 2017

3

1 reference

27 June 2017

175-181

1 reference

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

27 June 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00842.X

Relationship between fasting plasma glucose and glycosylated hemoglobin: potential for false-positive diagnoses of type 2 diabetes using new diagnostic criteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00842.X

Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial. The Care Investiga

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00842.X

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00842.X

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00842.X

The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00842.X

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00842.X

Estimating the microvascular benefits of screening for type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00842.X

Should we screen for type 2 diabetes? Evaluation against National Screening Committee criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00842.X

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00842.X

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00842.X

Effects of Calcium-Channel Blockade in Older Patients with Diabetes and Systolic Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00842.X

10.1046/J.1464-5491.2003.00842.X

21 January 2018

Identifiers

DOI

1 reference

27 June 2017

1 reference